Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/18580957

Download in:

View as

General Info

PMID
18580957